Transcode Therapeutics, INC. (RNAZ) SEC Filings — 2025

Filings

• Transcode Therapeutics Files 8-K Amendment — 8-K/A · Dec 23, 2025
• Transcode Therapeutics, INC. 8-K Filing — 8-K · Dec 22, 2025
• Transcode Therapeutics, INC. 8-K Filing — 8-K · Dec 11, 2025
• Transcode's Net Loss Nearly Doubles Amidst Warrant Revaluation, Strategic Acquisition — 10-Q · Nov 14, 2025
• Transcode Therapeutics Files 8-K — 8-K · Oct 27, 2025
• Transcode Therapeutics Files 8-K/A Amendment — 8-K/A · Oct 17, 2025
• Transcode Therapeutics Files 8-K — 8-K · Oct 14, 2025
• Transcode Therapeutics Files 8-K Amendment — 8-K/A · Oct 8, 2025
• Transcode Therapeutics Enters Material Definitive Agreement — 8-K · Oct 3, 2025
• Transcode Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Sep 2, 2025
• Transcode's Net Loss Widens to $16.36M Amid Warrant Revaluation — 10-Q · Aug 14, 2025
• Transcode Therapeutics Seeks Shareholder Approval for Director Elections, Expanded Stock Plan — DEF 14A · Jul 15, 2025
• Transcode Therapeutics Files 8-K on Shareholder Nominations — 8-K · Jun 13, 2025
• Transcode Therapeutics Q1 2025 10-Q Filed — 10-Q · May 14, 2025
• Transcode Therapeutics Faces Delisting Concerns — 8-K · May 7, 2025
• Transcode Therapeutics Files 8-K on Security Holder Rights — 8-K · May 5, 2025
• Transcode Therapeutics Files 8-K — 8-K · May 2, 2025
• Transcode Therapeutics Files 2024 Annual Report Amendment — 10-K/A · Apr 30, 2025
• Transcode Therapeutics Files 8-K — 8-K · Apr 21, 2025
• TransCode Therapeutics Seeks Shareholder Approval for Reverse Stock Split — DEFA14A · Apr 16, 2025
• Transcode Therapeutics Files 2024 10-K — 10-K · Apr 15, 2025
• TransCode Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 11, 2025
• Transcode Therapeutics Enters Material Definitive Agreement — 8-K · Mar 25, 2025
• Transcode Therapeutics Files 8-K — 8-K · Feb 25, 2025
• Transcode Therapeutics Files 8-K — 8-K · Feb 4, 2025